Business Wire

Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced preliminary three- and four-year functional ...
Business Wire

Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

“Additionally, M6-C patients in the study had a low rate of revision surgery compared to the ACDF cohort. Patients in the study will be monitored out to 10 years post-op as we continue to compile the ...
Yahoo Finance

Orthofix (OFIX) Reaches Milestone for M6-C Disc Implants

Orthofix Medical Inc. OFIX attained a milestone with more than 60,000 M6-C artificial cervical discs being implanted around the world. TheM6-C disc is a next-generation artificial disc, which is ...
Nasdaq

Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS

Data for the patients implanted with the M6-C disc in this pivotal study show retention of statistically significant benefits in disability and neck, shoulder and arm pain scores at three and four ...